The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity (Q74455664)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

main subject

anemia of prematurity

1 reference

Bader D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Kugelman A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Maor-Rogin N

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Weinger-Abend M

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Hershkowitz S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Tamir A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Lanir A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Attias D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Barak M

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

published in

Journal of Perinatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

215-220

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533837%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7200522

7 January 2021

The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7200522

7 January 2021

Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7200522

7 January 2021

Postnatal changes in erythropoietin levels in untransfused premature infants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7200522

7 January 2021

Potential for treatment of anaemia of prematurity with recombinant human erythropoietin: preliminary results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7200522

7 January 2021

Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7200522

7 January 2021

Erythropoietin (Epo), protein and iron supplementation and the prevention of anaemia of prematurity: effects on serum immunoreactive Epo, growth and protein and iron metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7200522

7 January 2021

A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7200522

7 January 2021

Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7200522

7 January 2021

Iron status of preterm low birthweight infants and their response to oral iron

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7200522

7 January 2021

Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7200522

7 January 2021

Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7200522

7 January 2021